NASDAQ · Biotechnology

Aurinia Pharmaceuticals Inc (AUPH) Stock

$16.22 +1.31% NASDAQ: AUPH Healthcare

Valuation

MetricValue
Price$16.22
Market Cap$2.09B
P/E Ratio6.71
P/B Ratio3.35
P/S Ratio6.54
EPS (TTM)$0.00
52-Week High$19.25
52-Week Low$10.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE59.00%
ROA39.65%
ROCE21.77%
Gross Margin37.10%
Operating Margin37.10%
Net Margin100.84%
Debt/Equity0.10
Current Ratio5.23

Annual Financials (USD)

Metric20212022202320242025
Revenue$46.0M$134.0M$176.0M$235.0M$283.0M
Operating Profit$-181.0M$-111.0M$-92.0M$-5.0M$105.0M
Net Profit$-181.0M$-108.0M$-78.0M$6.0M$287.0M
EPS$-1.40$-0.76$-0.54$0.04$2.07
Op Margin-396.3%-83.2%-52.2%-2.0%37.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$543.0M$471.0M$548.0M$551.0M$752.0M
Total Liabilities$64.0M$65.0M$170.0M$173.0M$170.0M
Cash$232.0M$94.0M$49.0M$83.0M$80.0M
Borrowings$9.0M$8.0M$98.0M$79.0M$75.0M

Latest News

Sector Update: Healthcare Stocks Fall Monday Afternoon MT Newswires · Jul 6, 2026 Aurinia Pharmaceuticals Initiates Phase 4 PRESERVE Study in Lupus Nephritis Combination Therapy MT Newswires · Jul 6, 2026 Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis Business Wire · Jul 6, 2026 Aurinia (AUPH) Upgraded to Strong Buy: Here's Why Zacks · Jul 2, 2026 Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now? Insider Monkey · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-158.0M$-80.0M$-33.0M$44.0M$136.0M
Investing Cash Flow$-105.0M$-61.0M$-7.0M$39.0M$-33.0M
Financing Cash Flow$24.0M$2.0M$5.0M$-37.0M$-108.0M
Net Cash Flow$-40.0M$-138.0M$-45.0M$35.0M$-3.0M
Free Cash Flow$-159.0M$-80.0M$-34.0M$44.0M$135.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA10.18
FCF Yield8.53%
Quick Ratio4.97
Interest Coverage17.79
Return 1Y72.64%
Return 3Y40.13%
Return 5Y35.07%

Ownership

Insiders Held7.53%
Institutions Held60.33%
Institutions Float Held65.25%
Institutional HolderSharesReport Date
Tang Capital Management, LLC12,229,5002026-03-31
Blackrock Inc.7,845,5212026-03-31
NEA Management Company, LLC3,969,8342026-03-31
Two Sigma Investments, LP3,428,7052026-03-31
Arrowstreet Capital, Limited Partnership3,284,3682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (AUPH) stock trades at $16.22 with a market capitalization of $2.09B. The stock is valued at a price-to-earnings (P/E) ratio of 6.71, price-to-book of 3.35, price-to-sales of 6.54. Over the past 52 weeks the stock has ranged between $10.90 and $19.25, and currently trades 15.7% below its 52-week high.

On profitability, Aurinia Pharmaceuticals Inc generates a return on equity (ROE) of 59.00% — well above the market average, a sign of a high-quality business, return on capital employed of 21.77%, an operating margin of 37.10%, a net profit margin of 100.84%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides